Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Masafumi Kinoshita"'
Publikováno v:
Liang you shipin ke-ji, Vol 28, Iss 6, Pp 29-37 (2020)
In Hokkaido, improving appearance quality of non-glutinous rice grain nearly up to those of varieties in the area south of Tohoku district has been the important breeding objective for a long time. For decreasing immature grain such as milky white an
Externí odkaz:
https://doaj.org/article/b4eeedf1d1c646f5b275f9b29306f26c
Autor:
Ryuji Yamamoto, Eiji Yoden, Noboru Tanaka, Masafumi Kinoshita, Atsushi Imakiire, Tohru Hirato, Kohtaro Minami
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 27, Iss , Pp 100758- (2021)
Pabinafusp alfa is a fusion protein comprising a humanized anti-human transferrin receptor (TfR) antibody and human iduronate-2-sulfatase. It was developed as a novel modality to target central nervous system-related symptoms observed in patients wit
Externí odkaz:
https://doaj.org/article/5e52b45ea09645e9b710b6de626d81d7
Autor:
Kohtaro Minami, Hideto Morimoto, Hiroki Morioka, Atsushi Imakiire, Masafumi Kinoshita, Ryuji Yamamoto, Tohru Hirato, Hiroyuki Sonoda
Publikováno v:
International journal of molecular sciences. 23(19)
Heparan sulfate (HS) is an essential glycosaminoglycan (GAG) as a component of proteoglycans, which are present on the cell surface and in the extracellular matrix. HS-containing proteoglycans not only function as structural constituents of the basal
Publikováno v:
2022 IEEE 10th International Conference on Information, Communication and Networks (ICICN).
Autor:
Tohru Hirato, Kohtaro Minami, Masafumi Kinoshita, Eiji Yoden, Atsushi Imakiire, Ryuji Yamamoto, Noboru Tanaka
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 27, Iss, Pp 100758-(2021)
Molecular Genetics and Metabolism Reports
Molecular Genetics and Metabolism Reports
Pabinafusp alfa is a fusion protein comprising a humanized anti-human transferrin receptor (TfR) antibody and human iduronate-2-sulfatase. It was developed as a novel modality to target central nervous system-related symptoms observed in patients wit
Autor:
Masafumi Kinoshita, Kohtaro Minami, Kenichi Takahashi, Tohru Hirato, Haruna Takagi, Sachiho Kida, Ryuji Yamamoto, Yuri Koshimura, Eiji Yoden, Hiroyuki Sonoda, Hideto Morimoto, Noboru Tanaka
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy. 29(5)
Mucopolysaccharidosis II (MPS II), a lysosomal storage disease caused by mutations in iduronate-2-sulfatase (IDS), is characterized by a wide variety of somatic and neurologic symptoms. The currently approved intravenous enzyme replacement therapy wi
Publikováno v:
MobileCloud
In an edge computing application, cloud-side process and edge-side process run individually. This distributed process of an application fulfilling one common goal results in low readability of codes and additional maintenance cost. To address this is
Publikováno v:
Journal of Information Processing. 25:199-208
Autor:
Kenichi Takahashi, Kohtaro Minami, Ryuji Yamamoto, Hiroyuki Sonoda, Hideto Morimoto, Sachiho Kida, Masafumi Kinoshita, Haruna Takagi, Noboru Tanaka, Tohru Hirato, Yuri Koshimura, Eiji Yoden
Publikováno v:
Molecular Genetics and Metabolism. 132:S73
Autor:
Tadao Shibasaki, Ryuji Yamamoto, Sachiho Kida, Masafumi Kinoshita, Hideto Morimoto, Noboru Tanaka, Katsuhiko Tachibana
Publikováno v:
Molecular genetics and metabolism. 125(1-2)
Mucopolysaccharidosis type II (MPS II or Hunter syndrome) is a lysosomal storage disorder caused by a deficiency of iduronate-2-sulfatase (IDS), an enzyme that catabolizes glycosaminoglycans (GAGs) including heparan sulfate (HS) and dermatan sulfate